Defining a role for laquinimod in multiple sclerosis

nork Kieseier, Bernd C.
Argitaratua 2014

Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis

nork Kieseier, Bernd C., Benamor, Myriam
Argitaratua izan da Neurol Ther (2014)

Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration

nork Szepanowski, Fabian, Kieseier, Bernd C.
Argitaratua izan da Neural Regen Res (2016)

Innovative Monoclonal Antibody Therapies in Multiple Sclerosis

nork Linker, Ralf A., Kieseier, Bernd C.
Argitaratua 2008

Atacicept: targeting B cells in multiple sclerosis

nork Hartung, Hans-Peter, Kieseier, Bernd C.
Argitaratua 2010

Chemotherapeutics in the treatment of multiple sclerosis

nork Kieseier, Bernd C., Jeffery, Douglas R.
Argitaratua 2010

Immunosuppressive agents in multiple sclerosis

nork Neuhaus, Oliver, Kieseier, Bernd C., Hartung, Hans-Peter
Argitaratua izan da Neurotherapeutics (2007)

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner

nork Oreja-Guevara, Celia, Wiendl, Heinz, Kieseier, Bernd C., Airas, Laura
Argitaratua 2014

Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab

nork Lauenstein, Ann-Sophie, Stettner, Mark, Kieseier, Bernd C, Lensch, Eckart
Argitaratua 2014

Heat exposure and bicycling trigger recurrent aseptic meningitis: a case report

nork Stuve, Olaf, Marder, Ellen, Okai, Annette, Stettner, Mark, Kieseier, Bernd C
Argitaratua izan da BMC Neurol (2014)

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

nork Leussink, Verena I., Hartung, Hans-Peter, Kieseier, Bernd C., Stettner, Mark
Argitaratua izan da Ther Adv Neurol Disord (2016)

Novel pathomechanisms in inflammatory neuropathies

nork Schafflick, David, Kieseier, Bernd C., Wiendl, Heinz, Meyer zu Horste, Gerd
Argitaratua izan da J Neuroinflammation (2017)

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

nork Warnke, Clemens, Wiendl, Heinz, Hartung, Hans-Peter, Stüve, Olaf, Kieseier, Bernd C
Argitaratua 2010

Pathogenesis and Treatment of Immune-Mediated Neuropathies

nork Lehmann, Helmar C., zu Horste, Gerd Meyer, Kieseier, Bernd C., Hartung, Hans-Peter
Argitaratua 2009

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

nork Warnke, Clemens, Stüve, Olaf, Hartung, Hans-Peter, Fogdell-Hahn, Anna, Kieseier, Bernd C
Argitaratua 2011

Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model

nork Stangel, Martin, Penner, Iris Katharina, Kallmann, Boris A., Lukas, Carsten, Kieseier, Bernd C.
Argitaratua izan da Ther Adv Neurol Disord (2015)

Review of teriflunomide and its potential in the treatment of multiple sclerosis

nork Warnke, Clemens, Meyer zu Hörste, Gerd, Hartung, Hans-Peter, Stüve, Olaf, Kieseier, Bernd C
Argitaratua 2009

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity

nork Leussink, Verena Isabell, Husseini, Leila, Warnke, Clemens, Broussalis, Erasmia, Hartung, Hans-Peter, Kieseier, Bernd C.
Argitaratua 2012

Peginterferon beta-1a reduces disability worsening in relapsing–remitting multiple sclerosis: 2-year results from ADVANCE

nork Newsome, Scott D., Kieseier, Bernd C., Liu, Shifang, You, Xiaojun, Kinter, Elizabeth, Hung, Serena, Sperling, Bjoern
Argitaratua izan da Ther Adv Neurol Disord (2016)

Isoniazid-induced polyneuropathy in a tuberculosis patient – implication for individual risk stratification with genotyping?

nork Stettner, Mark, Steinberger, Daniela, Hartmann, Christian J, Pabst, Tatjana, Konta, Lidija, Hartung, Hans Peter, Kieseier, Bernd C
Argitaratua izan da Brain Behav (2015)